Toxicological barriers to providing better drugs

Area of Science:

• Toxicology
• Pharmacology
• Regulatory Science

Background:

• The development of new pharmaceutical remedies is essential to address unmet medical needs.
• Current toxicologic requirements and regulatory processes present significant challenges to drug innovation.

Purpose of the Study:

• To identify and analyze the conceptual, regulatory, and economic obstacles hindering rational toxicological testing and new drug development.
• To advocate for reforms in toxicologic testing and regulatory policies to facilitate the creation of novel therapeutics.

Main Methods:

• Review of existing toxicological testing paradigms and their limitations.
• Analysis of regulatory barriers, including bureaucratic demands and consumer group influences.
• Examination of economic factors impacting drug development.
• Case study analysis of specific regulatory decisions.

Main Results:

• Misplaced confidence in animal testing, inadequate risk-benefit analyses, and proliferation of tests with uncertain validity impede progress.
• Regulatory agencies face pressure, leading to demands for product superiority and costly post-marketing surveillance.
• Economic obstacles are exacerbated by increasing toxicologic study requirements.
• Examples of suboptimal regulatory decisions highlight systemic issues.

Conclusions:

• Reforming toxicologic testing and regulatory frameworks is imperative to accelerate the development of safe and effective new medicines.
• A balanced approach considering scientific validity, risk-benefit, and economic feasibility is needed.
• Addressing these challenges will ultimately benefit patients by ensuring access to innovative treatments.